期刊文献+

雄激素对体外成骨细胞OPG及其配体基因表达的影响 被引量:8

Regulation of estrogen receptor expression by androgens (Histomorphometry) in osteoblastic cells
暂未订购
导出
摘要 目的检测小鼠胎鼠成骨细胞体外培养并将不同浓度雄激素干预后,OPG和OPGLmRNA表达的变化,探讨雄激素在成骨细胞介导破骨细胞分化、活化过程中的调控机制。方法分离得到小鼠胎鼠颅盖骨成骨细胞,培养传代并选择第二代细胞用于实验;对第二代成骨细胞实施含10-10mol/L、10-9mol/L、10-8mol/L3种浓度雄激素的培养液干预;抽提细胞RNA,采用RT-PCR方法半定量观察成骨细胞中OPG和OPGL基因mRNA表达的变化。结果实验选用的各浓度组均未出现细胞毒性反应,雄激素干预使成骨细胞中OPG基因表达上调,而OPGL与OPG比率随时间呈递减趋势。结论雄激素可以特异性地在转录水平调节成骨细胞中OPG和OPGL基因的表达。 Objective To investigate the effects of androgen on the expression of OPG and OPGL, and to further clarify the mechanism of regulation of androgens on osteoblast in the process of inducing osteoclast differentiation and activation. Methods The second-passage osteoblasts that were tested to be characterized as being of osteoblastic phenotype were used in experiments; androgen were derided into 3 groups of 10^-10 mol/L. 10^-9 mol/L, 10^-8mol/L and then exert influence on osteoblasts; mRNA expressions of OPG and OPGL were semi-quantified by RT-PCR. Results No cell toxicity was found in all concentrations we used in experiments. The expression of OPG in osteoblasts was significiantly increased and up-regulated by androgen, and androgen promoted a decrease in the ratio of OPGL and OPG with time. Conclusion Androgen can regulate the expression of OPG and OPGL mRNA in gene-level in osteoblasts.
出处 《中国骨质疏松杂志》 CAS CSCD 2007年第2期77-81,共5页 Chinese Journal of Osteoporosis
基金 上海市高校科学技术发展基金项目(03BK26)
关键词 雄激素 成骨细胞 骨保护素(OPG) 骨保护素配体(OPGL) 基因表达 Androgen Osteoblast OPG OPGL Gene expression
  • 相关文献

参考文献10

  • 1Lories RJU,Luyten FP.Osteoprotegerin and Osteoprotegerin-ligand balance:A new paradigm in bone metabolism providing new therapeutic targets.Clinical Rheumatology,2001,20:3-9.
  • 2Lacey DL,Times E,Tan HL,et al.Osteoprotegerin Ligand is a cytokine that regulate osteoclast differentiation and activation.Cell,1998,93:165-176.
  • 3Nakagawa N,Konosaki M,yamaguchi K,et al.RANK is the essential signaling receptor for osteoclast differentiation factor in osteoclastogenesis.Biochem Biophys Res Commun,1998,253:395-400.
  • 4Yanfei LM,Rick LC,David LH,et al.Catabolic effects of continuous human PTH (1-38) in vivo is associated with sustained stimulation of RANKL and inhibition of osteoprotegerin and gene-associated bone formation.Endocrinology,2001,142:4047-4054.
  • 5Larry P,Matthew K,Jeffery J,et al.Androgens regulate bone resorption activity of isolated osteoclasts in vitro.Cell Biology,1999,96:505-510.
  • 6Gori F,Hotbaucer LC,Conover CA,et al.Effects of androgens on the insulin-like growth factor system in an androgen-responsive human osteoblastic cell line.Endocrinology,1999,140:5579-5586.
  • 7Liu XH,Alexander K,Shen Y,et al.Cross-Talk between the Interleukin-6 and Prostaglandin E2 Signaling Systems Results in Enhancement of Osteoclastogenesis through Effects on the Osteoprotegerin/Receptor Activator of Nuclear Factor-B (RANK)Ligand/RANK System.Endocrinology,2005,146:1991-1998.
  • 8Huber DM,Bendixen AC,Pathrose P,et al.Andogens suppress osteoclast formation induced by RANKL and macrophage-colony stimulating factor.Endocrinology,2001,142:3800-3808.
  • 9Jimi E,Nakamura I,Duong LT,et al.Interleukin 1 induces multinuclertion and bone-resorbing activity of osteoclasts in the absence of osteoblasts/stromal cells.Exp Cell Res,1999,247:84-93.
  • 10Kobayashi K,Takabashi I,Jimi E,et al.Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction.J Exp Med,2000,191:275-285.

同被引文献136

引证文献8

二级引证文献93

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部